Genomewide association study identifies no major founder variant in Caucasian moyamoya disease

Journal of Genetics

Volumn 92, Issue 3, 2013, Pages 605-609

  Liu, Wanyang ^a,g   Senevirathna, S T M L D ^a   Hitomi, Toshiaki ^a   Kobayashi, Hatasu ^a   Roder, Constantin ^b   Herzig, Roman ^c   Kraemer, Markus ^d   Voormolen, Maurits H J ^e   Cahová, Pavlína ^f   Krischek, Boris ^b   Koizumi, Akio ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c PALACKÝ UNIVERSITY   (Czech Republic)

^d Alfried Krupp von Bohlen und Halbach Hospital   (Germany)

^e ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^f UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^g CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Caucasian; founder variant; genomewide association study; moyamoya disease; suggestive association

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; ETHNOLOGY; FEMALE; FOUNDER EFFECT; GENETIC ASSOCIATION; GENETICS; HUMAN; MALE; MOYAMOYA DISEASE; NUCLEOTIDE SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOUNDER EFFECT; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MOYAMOYA DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84899451186     PISSN: 00221333     EISSN: 09737731     Source Type: Journal    
DOI: 10.1007/s12041-013-0304-5     Document Type: Article

References (13)

1. Fukuda M. and Kuroda T. S. 2002 Slac2-c (synaptotagmin-like protein homologue lacking C2 domains-c), a novel linker protein that interacts with Rab27, myosin Va/VIIa, and actin. J. Biol. Chem. 277, 43096-43103.
2. Goto Y. and Yonekawa Y. 1992 Worldwide distribution of moyamoya disease. Neurol. Med. Chir. (Tokyo)32, 883-886.
3. Guo D. C., Papke C. L., Tran-Fadulu V., Regalado E. S., Avidan N., Johnson R. J. et al. 2009 Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am. J. Hum. Genet. 84, 617-627.
4. Kuroda S. and Houkin K. 2008 Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 7, 1056-1066.
5. Liu W., Hashikata H., Inoue K., Matsuura N., Mineharu Y., Kobayashi H. et al. 2010 A rare Asian founder polymorphism of Raptor may explain the high prevalence of Moyamoya disease among East Asians and its low prevalence among Caucasians. Environ. Health Prev. Med. 15, 94-104.
6. Liu W., Morito D., Takashima S., Mineharu Y., Kobayashi H., Hitomi T. et al. 2011 Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One6, e22542.
7. Liu W., Harada K. H., Hitomi T., Kobayashi H. and Koizumi A. 2012 Distribution of moyamoya disease susceptibility polymorphism p. R4810K in RNF213 in East and Southeast Asian populations. Neurol. Med. Chir. (Tokyo)52, 299-303.
8. Miyatake S., Miyake N., Touho H., Nishimura-Tadaki A., Kondo Y., Okada I. et al. 2012 Homozygous c. 14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology78, 803-810.
9. Roder C., Peters V., Kasuya H., Nishizawa T., Wakita S., Berg D. et al. 2011 Analysis of ACTA2 in European Moyamoya disease patients. Eur. J. Paediatr. Neurol. 15, 117-122.
10. Shimojima K. and Yamamoto T. 2009 ACTA2 is not a major disease-causing gene for moyamoya disease. J. Hum. Genet. 54, 687-688.
11. Suzuki J. and Takaku A. 1969 Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch. Neurol. 20, 288-299.
12. Takeuchi K. and Shimizu K. 1957 Hypogenesis of bilateral internal carotid arteries. Brain Nerve9, 37-43.
13. Wu Z., Jiang H., Zhang L., Xu X., Zhang X., Kang Z. et al. 2012 Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population. PLoS One7, e48179.